Cargando…

PopB-PcrV Interactions Are Essential for Pore Formation in the Pseudomonas aeruginosa Type III Secretion System Translocon

The type III secretion system (T3SS) is a syringe-like virulence factor that delivers bacterial proteins directly into the cytoplasm of host cells. An essential component of the system is the translocon, which creates a pore in the host cell membrane through which proteins are injected. In Pseudomon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kundracik, Emma, Trichka, Josephine, Díaz Aponte, José, Roistacher, Alicia, Rietsch, Arne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600203/ https://www.ncbi.nlm.nih.gov/pubmed/36154276 http://dx.doi.org/10.1128/mbio.02381-22

Ejemplares similares

Identification of Small Molecules Blocking the Pseudomonas aeruginosa Type III Secretion System Protein PcrV
por: Sundin, Charlotta, et al.
Publicado: (2021)

Immunopotentiating properties of chimeric OprF-OprI-PopB protein against Pseudomonas aeruginosa PAO1 in the infected burned rat model
por: Sabzehali, Fattaneh, et al.
Publicado: (2022)

Rational Design of a Chimeric Derivative of PcrV as a Subunit Vaccine Against Pseudomonas aeruginosa
por: Wan, Chuang, et al.
Publicado: (2019)

A Live Salmonella Vaccine Delivering PcrV through the Type III Secretion System Protects against Pseudomonas aeruginosa
por: Aguilera-Herce, Julia, et al.
Publicado: (2019)

Self-assembled ferritin nanoparticles displaying PcrV and OprI as an adjuvant-free Pseudomonas aeruginosa vaccine
por: Li, Yuhang, et al.
Publicado: (2023)

Modified Needle-Tip PcrV Proteins Reveal Distinct Phenotypes Relevant to the Control of Type III Secretion and Intoxication by Pseudomonas aeruginosa
por: Sato, Hiromi, et al.
Publicado: (2011)

Effects of monoclonal anti-PcrV antibody on Pseudomonas aeruginosa-induced acute lung injury in a rat model
por: Faure, Karine, et al.
Publicado: (2003)

Production of an Antibody Fragment (scFv) Targeting PcrV Protein of Pseudomonas aeruginosa in Fed-Batch Cultivation Mode
por: Karam, Saba, et al.
Publicado: (2021)

Vaccination of mice with hybrid protein containing Exotoxin S and PcrV with adjuvants alum and MPL protects Pseudomonas aeruginosa infections
por: Asadi Karam, Mohammad Reza, et al.
Publicado: (2022)

NLRP3 selectively drives IL-1β secretion by Pseudomonas aeruginosa infected neutrophils and regulates corneal disease severity
por: Minns, Martin S., et al.
Publicado: (2023)

Type III secretion proteins PcrV and PcrG from Pseudomonas aeruginosa form a 1:1 complex through high affinity interactions
por: Nanao, Max, et al.
Publicado: (2003)

Protective Effect of DNA Vaccine Encoding Pseudomonas Exotoxin A and PcrV against Acute Pulmonary P. aeruginosa Infection
por: Jiang, Mingzi, et al.
Publicado: (2014)

Development of a Chimeric Vaccine Against Pseudomonas aeruginosa Based on the Th17-Stimulating Epitopes of PcrV and AmpC
por: Wang, Ying, et al.
Publicado: (2021)

Strong immune responses and protection of PcrV and OprF-I mRNA vaccine candidates against Pseudomonas aeruginosa
por: Wang, Xingyun, et al.
Publicado: (2023)

Type III Secretion Protein, PcrV, Impairs Pseudomonas aeruginosa Biofilm Formation by Increasing M1 Macrophage-Mediated Anti-bacterial Activities
por: Yu, Hua, et al.
Publicado: (2020)

Protective Efficacy of the Trivalent Pseudomonas aeruginosa Vaccine Candidate PcrV-OprI-Hcp1 in Murine Pneumonia and Burn Models
por: Yang, Feng, et al.
Publicado: (2017)

Multi-Functional Characteristics of the Pseudomonas aeruginosa Type III Needle-Tip Protein, PcrV; Comparison to Orthologs in other Gram-negative Bacteria
por: Sato, Hiromi, et al.
Publicado: (2011)

Protective Efficacy of the OprF/OprI/PcrV Recombinant Chimeric Protein Against Pseudomonas aeruginosa in the Burned BALB/c Mouse Model
por: Fakoor, Mohammad Hadi, et al.
Publicado: (2020)

Outer Membrane Vesicles Displaying a Heterologous PcrV-HitA Fusion Antigen Promote Protection against Pulmonary Pseudomonas aeruginosa Infection
por: Li, Peng, et al.
Publicado: (2021)

The Pseudomonas aeruginosa Type III Translocon Is Required for Biofilm Formation at the Epithelial Barrier
por: Tran, Cindy S., et al.
Publicado: (2014)

The Type III Secretion Translocation Pore Senses Host Cell Contact
por: Armentrout, Erin I., et al.
Publicado: (2016)

The type 3 secretion system requires actin polymerization to open translocon pores
por: Russo, Brian C., et al.
Publicado: (2021)

697. Pseudomonas aeruginosa PcrV and Psl, the Molecular Targets of Bispecific Monoclonal Antibody MEDI3902, Are Conserved Among Diverse Hospital Isolates Collected From an International Surveillance Study
por: Tabor, David E
Publicado: (2018)

Diversity of Virulence Phenotypes among Type III Secretion Negative Pseudomonas aeruginosa Clinical Isolates
por: Toska, Jonida, et al.
Publicado: (2014)

Pseudomonas aeruginosa PcrV Enhances the Nitric Oxide-Mediated Tumoricidal Activity of Tumor-Associated Macrophages via a TLR4/PI3K/AKT/mTOR-Glycolysis-Nitric Oxide Circuit
por: Yu, Hua, et al.
Publicado: (2021)

Injection of Pseudomonas aeruginosa Exo Toxins into Host Cells Can Be Modulated by Host Factors at the Level of Translocon Assembly and/or Activity
por: Verove, Julien, et al.
Publicado: (2012)

Characterization of a novel mCH3 conjugated anti-PcrV scFv molecule
por: Komijani, Samira, et al.
Publicado: (2021)

PcrG protects the two long helical oligomerization domains of PcrV, by an interaction mediated by the intramolecular coiled-coil region of PcrG
por: Basu, Abhishek, et al.
Publicado: (2014)

Activation of Shigella flexneri type 3 secretion requires a host-induced conformational change to the translocon pore
por: Russo, Brian C., et al.
Publicado: (2019)

Host Response and Bacterial Virulence Factor Expression in Pseudomonas aeruginosa and Streptococcus pneumoniae Corneal Ulcers
por: Karthikeyan, Rajapandian SivaGanesa, et al.
Publicado: (2013)

Acrobatic flexibility of the translocon
por: LeBrasseur, Nicole
Publicado: (2007)

The SR finds the translocon
por: LeBrasseur, Nicole
Publicado: (2008)

Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study
por: Reyes, Jinnethe, et al.
Publicado: (2023)

A new role for BiP: closing the aqueous translocon pore during protein integration into the ER membrane
por: Haigh, Nora G., et al.
Publicado: (2002)

Translocon: don't pass me by
por: LeBrasseur, Nicole
Publicado: (2003)

The Dynamic SecYEG Translocon
por: Oswald, Julia, et al.
Publicado: (2021)

Topological Analysis of the Type 3 Secretion System Translocon Pore Protein IpaC following Its Native Delivery to the Plasma Membrane during Infection
por: Russo, Brian C., et al.
Publicado: (2019)

Characterization of translocon proteins in the type III secretion system of Lawsonia intracellularis
por: Huang, Beibei, et al.
Publicado: (2023)

Quantification of Pseudomonas aeruginosa in multispecies biofilms using PMA-qPCR
por: Tavernier, Sarah, et al.
Publicado: (2015)

TRAP builds a better translocon
por: Dove, Alan W.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_0pm7qd5hni7odjgc6v61lrib14